These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35871396)

  • 21. Clinical utility of molecular and flow cytometric markers in chronic lymphocytic leukaemia.
    Sulda ML; Kuss BJ; Hall RK; Bailey S; Macardle PJ
    Intern Med J; 2012 Feb; 42(2):137-46. PubMed ID: 20561095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reassessing the chronic lymphocytic leukemia International Prognostic Index in the era of targeted therapies.
    Langerbeins P; Giza A; Robrecht S; Cramer P; von Tresckow J; Al-Sawaf O; Fink AM; Fürstenau M; Kutsch N; Simon F; Goede V; Hoechstetter M; Niemann CU; da Cunha-Bang C; Kater A; Dubois J; Gregor M; Staber PB; Tausch E; Schneider C; Stilgenbauer S; Eichhorst B; Fischer K; Hallek M
    Blood; 2024 Jun; 143(25):2588-2598. PubMed ID: 38620092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic factors for chronic lymphocytic leukemia with typical and atypical immunophenotype].
    Cao X; Xu W; Wu YJ; Qiao C; Liu Q; Fan L; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):450-3. PubMed ID: 19954596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study.
    D'Arena G; Vitale C; Pietrantuono G; Villani O; Mansueto G; D'Auria F; Statuto T; D'Agostino S; Sabetta R; Tarasco A; Innocenti I; Autore F; Fresa A; Valvano L; Tomasso A; Cafaro L; Lamorte D; Laurenti L
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of Lymphoid enhancer-binding factor 1 (LEF-1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologic features.
    Soliman DS; Al-Kuwari E; Siveen KS; Al-Abdulla R; Chandra P; Yassin M; Nashwan A; Hilmi FA; Taha RY; Nawaz Z; El-Omri H; Mateo JM; Al-Sabbagh A
    Int J Lab Hematol; 2021 Jun; 43(3):515-525. PubMed ID: 33314668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
    Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V
    Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers.
    Kunnumbrath A; Singh N; Gupta AK; Chowdhury N; Nath UK; Chandra H
    J Lab Physicians; 2022 Dec; 14(4):435-442. PubMed ID: 36531546
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.
    Lanasa MC; Allgood SD; Slager SL; Dave SS; Love C; Marti GE; Kay NE; Hanson CA; Rabe KG; Achenbach SJ; Goldin LR; Camp NJ; Goodman BK; Vachon CM; Spector LG; Rassenti LZ; Leis JF; Gockerman JP; Strom SS; Call TG; Glenn M; Cerhan JR; Levesque MC; Weinberg JB; Caporaso NE
    Leukemia; 2011 Sep; 25(9):1459-66. PubMed ID: 21617698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features.
    Shuai W; Lin P; Strati P; Patel KP; Routbort MJ; Hu S; Wei P; Khoury JD; You MJ; Loghavi S; Tang Z; Fang H; Thakral B; Medeiros LJ; Wang W
    Blood Cancer J; 2020 Aug; 10(8):86. PubMed ID: 32848129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-G expression as a prognostic indicator in B-cell chronic lymphocytic leukemia.
    Attia MA; Nosair NA; Gawally A; Elnagar G; Elshafey EM
    Acta Haematol; 2014; 132(1):53-8. PubMed ID: 24557341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
    Zucchetto A; Caldana C; Benedetti D; Tissino E; Rossi FM; Hutterer E; Pozzo F; Bomben R; Dal Bo M; D'Arena G; Zaja F; Pozzato G; Di Raimondo F; Hartmann TN; Rossi D; Gaidano G; Del Poeta G; Gattei V
    Blood; 2013 Nov; 122(19):3317-21. PubMed ID: 24068493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of prognostic variables in chronic lymphocytic leukemia and association with disease stage.
    Attia HRM; Ibrahim MH; El-Aziz SHA; Abdelrahman AH; Sobeih ME; Hagag HAA; Yassa ME; Osman RA; Rawi R; El-Dayem OYA; Elsharkawi N; Abdelfattah R; Hassan NM
    Mol Clin Oncol; 2021 May; 14(5):100. PubMed ID: 33796290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.
    Nückel H; Switala M; Collins CH; Sellmann L; Grosse-Wilde H; Dührsen U; Rebmann V
    Clin Immunol; 2009 Jun; 131(3):472-80. PubMed ID: 19318232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia.
    Dal Bo M; Bulian P; Bomben R; Zucchetto A; Rossi FM; Pozzo F; Tissino E; Benedetti D; Bittolo T; Nanni P; Cattarossi I; Zaina E; Chivilò H; Degan M; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Del Principe MI; Del Poeta G; Rossi D; Gaidano G; Gattei V
    Leukemia; 2016 Oct; 30(10):2011-2018. PubMed ID: 27109509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression.
    Tissino E; Pozzo F; Benedetti D; Caldana C; Bittolo T; Rossi FM; Bomben R; Nanni P; Chivilò H; Cattarossi I; Zaina E; Norris K; Polesel J; Gentile M; Tripepi G; Moia R; Santinelli E; Innocenti I; Olivieri J; D'Arena G; Laurenti L; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Rossi D; Pepper C; Hartmann TN; Gaidano G; Del Poeta G; Gattei V; Zucchetto A
    Blood; 2020 Apr; 135(15):1244-1254. PubMed ID: 32006000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials.
    Soumerai JD; Ni A; Xing G; Huang J; Furman RR; Jones J; Sharman JP; Hallek M; Adewoye AH; Dubowy R; Dreiling L; Zelenetz AD
    Leuk Lymphoma; 2019 Jun; 60(6):1438-1446. PubMed ID: 30407886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotyping of Chronic Lymphocytic Leukemia.
    Falay M; Özet G
    Clin Lab; 2017 Oct; 63(10):1621-1626. PubMed ID: 29035453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
    Ahmad E; Steinberg SM; Goldin L; Hess CJ; Caporaso N; Kreitman RJ; Wiestner A; Wilson W; White T; Marti G; Stetler-Stevenson M
    Cytometry B Clin Cytom; 2008 Jul; 74(4):221-6. PubMed ID: 18431797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high-risk features and reduced treatment-free-intervals.
    Elizabeth S; Aidan K; David OB; Deirdre W; Sarah B; Emer A; Kanthi P; Crotty GM; Aileen W; Michelle C; Ruth C; Hilary O; Ashique K; Bacon CL; Emily S; McElligott AM; Fiona Q; Elisabeth V; Carmel W
    Eur J Haematol; 2022 Nov; 109(5):441-446. PubMed ID: 35776688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.